India has a great interest to supply the highest leve l of drugs to treat oncology, also Russia has an incentive to produce its own drugs, Andrey Kaprin, chief freelance oncologist of the Russian Health Ministry, director general of the National Medical Research Centre of Radiology, RAS academician, told RIA Novosti. "I see a very great interest of our colleagues from India, who definitely have a huge number of drugs, which are of the highest level of generics. Which, in fact, did not make it to the market, in particular, because European companies have already established themselves in our market. Such a market cannot be empty. So I think this is an incentive for us to produce our drugs, our equipment, our radionuclides. We already understand that our most important ally is ourselves," he said when asked about the shortage of oncology drugs. Kaprin also said that he had been visited by very well-known companies who were afraid of losing such a market, and there was no...